Company

InvivoPharm Inc. is a newly established contract research organization (CRO), founded in 2008 and located in Long Island, New York.  The core expertise of InvivoPharm is in the areas of receptor occupancy, autoradiography and radiolabeled drug binding.  

Facilities

Our office and laboratory are located at the Stony Brook University Technology Incubator at Calverton.

Management

Andrew Gifford, Ph.D. (President and Chief Scientific Officer)

In addition to being a founder of the company, Dr. Gifford has served for many years as a scientist in the radiopharmaceutical development program at Brookhaven National Laboratory and continues to maintain an active appointment there.  As a principal investigator in the program, Dr. Gifford has been responsible for preclinical studies on a variety of radiolabeled drugs.  Techniques employed at his academic laboratories include radioiodinations, radioligand binding assays and tissue and whole body autoradiography.  

Publication list for Dr. Gifford

Alison Liu, Ph.D.

Dr. Liu is a co-founder of the company.  She received her Ph.D. from Stony Brook University and has previously held postdoctoral appointments at both Cold Spring Harbor Laboratory and Rockefeller University.  Her academic research interests have been in the area of pharmacology and neuroscience using knockout and transgenic animal models.

Consultants

Charles R Ashby Jr, Ph.D.

Dr Ashby is a professor in pharmacology in the pharmaceutical Sciences Department at St. John's University.  His academic research interests have been primarily in the area of preclinical behavioral pharmacology of CNS-active drugs.  More recently, he has also been interested in mechanisms of microbial and cancer cell resistance to chemotherapeutic agents.